// October 11, 2023
Standards on the Frontlines: Responding to public health crises and strengthening sup...
Vulnerabilities or disruptions to the global medicine supply chain (including drug shortages) continue to make headlines.
Supply Chain
// June 24, 2024
Advancing regional manufacturing in Africa: Four key takeaways from the 77th World He...
Expanding regional manufacturing in Africa relies on capable suppliers and a predictable demand. Following the World Health Assembly, we explore four ways to advance medicines manufacturing on the continent. Read the blog.
// March 13, 2024
Producing maternal health supplies in sub-Saharan Africa ...
Understanding the landscape to expand, strengthen, and diversify African-based manufacturing
// September 10, 2024
Korea’s Minister of Food & Drug Safety: Addressing Medicines Supply Chain Resilience ...
Building on the momentum of recent high-level engagements with health agencies from around the world, USP hosted a delegation from the Republic of Korea’s (South Korea) National Institute of Food and Drug Safety Evaluation (NIFDS) at our U.S. hub in Rockville, MD.
// May 30, 2024
Public Health advocates call on policymakers to end drug shortages in the U.S. ...
Drug shortages pose a significant, ongoing threat to our healthcare system and to the patients who rely on medicine for their wellbeing and survival.
// October 24, 2023
Why cancer medicines are and continue to be vulnerable to drug shortages...
Analysis leveraging USP’s Medicine Supply Map suggests many of the essential cancer medicines have inherently vulnerable supply chains and are at greater risk for shortage compared to other generic medicines.
// September 21, 2023
Ensuring Product Safety: U.S. FDA Guidance on Testing High-Risk Drug Components for D...
Excipients, or inactive ingredients, in a drug formulation are critical components, comprising up to 90% of a drug formulation by volume and serving important functions such as improving stability and increasing bioavailability for targeted drug delivery. However, with so much focus on the quality of active ingredients in the complex pharmaceutical supply chain, the quality of inactive ingredients is, at times, overlooked.
// September 15, 2023
Pharmaceutical Continuous Manufacturing: Regulatory landscape in the spotlight at USP...
The science of pharmaceutical continuous manufacturing (PCM) may not be entirely new but increasing interest in adoption of advanced manufacturing technologies (AMT) including PCM among industry and policymakers in recent years has been accompanied by strong support by FDA.
// September 15, 2023
Show 11 More